Literature DB >> 15611668

p53 Transactivates the phosphatase MKP1 through both intronic and exonic p53 responsive elements.

Huanjie Yang1, Gen Sheng Wu.   

Abstract

The tumor suppressor p53 protein can negatively regulate mitogen-activated protein kinase (MAPK) signaling via the induction of MAPK phosphatases. We have recently described that MKP1, a member of the MAPK phosphatase family, is transcriptionally regulated by p53 via a p53 responsive element located in the second intron of the MKP1 gene. Here, we identify an additional p53 responsive element located in the third exon of the MKP1 gene. We demonstrated in reporter gene assays that p53 binds to this exonic element and transactivates MKP1. Furthermore, we showed that this exonic responsive element could be bound by p53 both in vitro and in vivo as demonstrated by gel shift and ChIP assays, respectively. Mutation of either exonic or intronic site resulted in a ~50% decrease in luciferase reporter activity, and loss of both sites completely abrogated p53-dependent transcription of MKP1. These results suggest that each element sufficiently confers p53 responsiveness and that both elements are required for its full activation. Thus, our results provide the mechanism by which p53 controls transcription of the MKP1 gene.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15611668     DOI: 10.4161/cbt.3.12.1370

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  8 in total

Review 1.  Mitogen-activated protein kinase phosphatase (MKP)-1 in immunology, physiology, and disease.

Authors:  Lyn M Wancket; W Joshua Frazier; Yusen Liu
Journal:  Life Sci       Date:  2011-12-13       Impact factor: 5.037

2.  Microarray expression profiling in 6-hydroxydopamine-induced dopaminergic neuronal cell death.

Authors:  Bokyung Park; Chang-Ki Oh; Won-Seok Choi; In Kwon Chung; Moussa B H Youdim; Young J Oh
Journal:  J Neural Transm (Vienna)       Date:  2011-09-09       Impact factor: 3.575

3.  MKP-1 antagonizes C/EBPβ activity and lowers the apoptotic threshold after ischemic injury.

Authors:  A Rininger; C Dejesus; A Totten; A Wayland; M W Halterman
Journal:  Cell Death Differ       Date:  2012-04-20       Impact factor: 15.828

4.  Identification of NURR1 as a mediator of MIF signaling during chronic arthritis: effects on glucocorticoid-induced MKP1.

Authors:  Jennifer A Ralph; Afsar U Ahmed; Leilani L Santos; Andrew R Clark; Jason McMorrow; Evelyn P Murphy; Eric F Morand
Journal:  Am J Pathol       Date:  2010-09-09       Impact factor: 4.307

5.  Mitogen-activated protein kinase phosphatase-1 (MKP-1) impairs the response to anti-epidermal growth factor receptor (EGFR) antibody cetuximab in metastatic colorectal cancer patients.

Authors:  C Montagut; M Iglesias; M Arumi; B Bellosillo; M Gallen; A Martinez-Fernandez; L Martinez-Aviles; I Cañadas; A Dalmases; E Moragon; L Lema; S Serrano; A Rovira; F Rojo; J Bellmunt; J Albanell
Journal:  Br J Cancer       Date:  2010-03-16       Impact factor: 7.640

6.  Cross-talk between the p38alpha and JNK MAPK pathways mediated by MAP kinase phosphatase-1 determines cellular sensitivity to UV radiation.

Authors:  Christopher J Staples; David M Owens; Jana V Maier; Andrew C B Cato; Stephen M Keyse
Journal:  J Biol Chem       Date:  2010-06-11       Impact factor: 5.157

7.  The transcription factor p53: not a repressor, solely an activator.

Authors:  Martin Fischer; Lydia Steiner; Kurt Engeland
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

8.  Celastrol Induces Autophagy by Targeting AR/miR-101 in Prostate Cancer Cells.

Authors:  Jianquan Guo; Xuemei Huang; Hui Wang; Huanjie Yang
Journal:  PLoS One       Date:  2015-10-16       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.